Related Experiment Video
Updated: Aug 20, 2025

05:48
A Behavioral Assay for Mechanosensation of MARCM-based Clones in Drosophila melanogaster
Published on: December 30, 2015
10.3K
An insecticide target in mechanoreceptor neurons
Xiaomu Qiao1, Xiaoyu Zhang1, Zhendong Zhou1
1Ministry of Agriculture Key Laboratory of Molecular Biology of Crop Pathogens and Insects, Institute of Insect Sciences, Zhejiang University, Hangzhou 310058, China.
Science Advances
|November 23, 2022
Summary
Researchers identified nicotinamidase (Naam) as a novel insecticide target using flonicamid in fruit flies. This discovery opens avenues for developing new pesticides and medicines targeting Naam.
Area of Science:
- Entomology
- Neuroscience
- Toxicology
Background:
- Numerous neurotoxic insecticides exist, yet their specific molecular targets remain largely unknown.
- Understanding insecticide targets is crucial for developing safer and more effective pest control strategies.
Purpose of the Study:
- To identify the molecular target of the insecticide flonicamid in *Drosophila*.
- To investigate the role of this target in insect physiology and insecticide resistance.
Main Methods:
- Utilized *Drosophila* melanogaster as a model organism.
- Employed genetic engineering to create flies with mutated nicotinamidase (Naam).
- Analyzed the effects of flonicamid metabolite TFNA-AM on Naam activity and insect behavior.
Main Results:
- Identified nicotinamidase (Naam) as the molecular target of flonicamid.
- Flonicamid's metabolite, TFNA-AM, inhibits Naam, leading to nicotinamide accumulation and impaired negative geotaxis in flies.
- Engineered flies with mutated Naam exhibited resistance to flonicamid and defects in gravity sensing.
- Bees possess a TFNA-AM-insensitive Naam due to gene duplication, conferring resistance to flonicamid.
Conclusions:
- Nicotinamidase (Naam) is a previously unrecognized molecular target for insecticides like flonicamid.
- TFNA-AM and species-specific Naam inhibitors show potential as novel insecticides, anthelmintics, and antimicrobials.
- The absence of Naam genes in vertebrates suggests a favorable safety profile for potential therapeutic applications.

